FDA
approval
· 2020-06-12
FDA Approved: TIVICAY PD — Original Application (ViiV Healthcare Company)
Summary
FDA approved Tivicay PD (dolutegravir sodium) under an original application for HIV-1 infection, introducing a new product formulation of dolutegravir.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TIVICAY PD (DOLUTEGRAVIR SODIUM)